A genome-wide association study of critically ill patients with COVID-19 identifies genetic signals that relate to important host antiviral defence mechanisms and mediators of inflammatory organ damage that may be targeted by repurposing drug treatments.
- Erola Pairo-Castineira
- Sara Clohisey
- J. Kenneth Baillie
